Per Persson, CEO of Acarix recently participated in the Navigator's newly launched interview series "Pejling". The interview is based on discussions related to how the overall changing conditions, due to COVID -19, affect different industries and companies.
See the interview with Per Persson here>>
Acarix was establish in 2009 and is listed on Nasdaq First North Growth Market. Acarix's CADScor@System uses an advanced sensor placed on the skin above the heart to listen to the sounds of cardiac contraction movement and turbulent flow. It has been designed to be an all-in-on system in the sense that the heart signal will be recorded, processed, and displayed as a patient specific score, the CAD-score, on the device screen.